Phoenicis Therapeutics
PrivateLast Round
VC Round
Aug 11, 2022
Company Overview
Phoenicis Therapeutics is a biotechnology company that develops recombinant protein-based therapies for rare, genetic, and inflammatory disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Phoenicis Therapeutics Comparables
Compare Phoenicis Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nova Anchora | 86% | |
| Aegle Therapeutics Corp | 82% | |
| Castle Creek Biosciences | 81% | |
Phoenicis Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Aug 11, 2022 |
Phoenicis Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CureDuchenne Ventures | VC Round |
| Congressionally Directed Medical Research Programs | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 11, 2022
$20M round from Cure EB and others.
Phoenicis Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Phoenicis Therapeutics's valuation, stock price, and market status.